Ashish Dandekar has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
CAMLINFINE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.4 pts more than Nifty Microcap 250 and 2.0 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Ashish Dandekar, who is associated with Camlin Fine Sciences as a promoter or person acting in concert, has filed a disclosure with the stock exchange under Regulation 31(4) of the SEBI Takeover Regulations. This regulation specifically deals with the creation, invocation, or release of encumbrances (such as pledges or liens) on shares. The filing confirms a pledge-related transaction involving his holdings in the company. However, the specific nature of the encumbrance—whether it is a new pledge, an invocation, or a release—and the percentage of shares involved are not detailed in the headline. Shareholders should look to the full disclosure document for the precise details of the transaction.
Pledge-related disclosures can affect stock sentiment depending on the nature of the transaction. A new pledge may raise concerns about funding pressures, while a release or invocation signals changing financial positions of promoters. Investors should review the full disclosure to understand the specifics.